What Is Thioflavin and How Is It Used in Research?

Thioflavin T (ThT) is a small benzothiazole dye that lights up brilliantly when it binds to amyloid fibrils, the abnormal protein clumps implicated in Alzheimer’s disease, Parkinson’s disease, and other conditions. Its close relative, Thioflavin S (ThS), serves a similar purpose in tissue staining. Since the late 1980s, ThT has become the workhorse fluorescent probe for detecting and quantifying amyloid aggregation in the lab, and its influence extends well beyond basic protein science into diagnostics, drug discovery, and even environmental sensing.

How ThT Produces Its Signal

ThT is what researchers call a “molecular rotor.” In ordinary liquid, the two ring systems that make up the molecule, a benzothiazole ring and an aminobenzene ring, can twist freely relative to each other. That internal twisting dumps the energy ThT absorbs from light as heat instead of fluorescence, so a solution of free ThT barely glows. When ThT slots into the rigid, ordered structure of an amyloid fibril, the surrounding environment locks those rings in place. Unable to twist, the molecule releases its absorbed energy as strong fluorescence instead.

This viscosity-dependent behavior was confirmed in solvent experiments showing that ThT fluorescence intensity rises dramatically as the surrounding environment becomes more rigid, and that the low fluorescence in thin solvents results from the molecule relaxing into a non-fluorescent twisted state.

The practical upshot is elegant: you add ThT to a sample, shine blue light on it, and if amyloid fibrils are present, you see green-yellow fluorescence. No fibrils, no signal. That on/off quality is what makes ThT so popular.

Where ThT Binds on Amyloid Fibrils

Amyloid fibrils share a common architecture in which protein strands stack into extended sheets. Along the surface of those sheets, side chains from neighboring strands create shallow grooves running parallel to the long axis of the fibril. ThT nestles into grooves formed by hydrophobic and aromatic amino acid side chains. Molecular simulations have shown that a groove spanning about four consecutive protein strands represents the minimum binding site ThT needs.

Because this groove architecture is a generic feature of amyloid structure rather than something unique to one protein, ThT binds to fibrils made from many different proteins: the amyloid-beta peptide of Alzheimer’s, the alpha-synuclein of Parkinson’s, the prion protein, insulin, and dozens more. The same simulations that mapped ThT’s binding site found that related imaging agents like Pittsburgh Compound B (PiB) target the same surface grooves, which helped explain why derivatives of ThT went on to become clinically useful brain-imaging tracers.

Tracking Amyloid Formation in Real Time

The single most common use of ThT in the laboratory is monitoring how amyloid fibrils form over time. A researcher places the protein of interest in a microplate well along with ThT, then periodically measures fluorescence. The resulting curve typically shows a lag phase (no fibrils yet), a rapid growth phase, and a plateau once the available protein has been consumed. This kinetic profile is the bread and butter of amyloid research.

⁴

ThT fluorescence correlates linearly with amyloid concentration across a wide range of dye concentrations, meaning you can use it not just to detect fibrils but to measure how much is present. Optimal ThT concentrations for the strongest signal sit around 20 to 50 micromolar. Above roughly 50 micromolar, the dye itself can start to influence the aggregation process, though how much it interferes depends on the protein being studied.

⁵

ThT has been used this way since 1989 and remains the standard approach for studying fibrillation kinetics and for evaluating whether a candidate molecule can slow or block aggregation.

⁶

Staining Brain Tissue for Alzheimer’s Pathology

While ThT dominates solution-based assays, its cousin Thioflavin S is the go-to dye for visualizing amyloid deposits in tissue sections under a fluorescence microscope. ThS is a sulfonated mixture derived from a similar chemical scaffold and stains both senile plaques and neurofibrillary tangles, the two hallmark lesions of Alzheimer’s disease. A modified ThS staining protocol produces bright lesions against a dark background, making it straightforward to count plaques and tangles automatically using image-analysis software.

⁷

Comparative studies have shown that an improved ThS staining technique detects neurofibrillary tangles with sensitivity similar to the classic Gallyas silver stain, a longstanding gold standard in neuropathology. An important distinction is that ThS fluorescence depends on the secondary structure of the protein aggregates themselves, whereas silver stains do not. This means ThS is specifically reporting on the cross-beta-sheet architecture that defines amyloid, not just on the presence of dense protein deposits.

⁸

Prion Disease Diagnostics

One of the most consequential clinical applications of ThT fluorescence is in a diagnostic test called RT-QuIC (real-time quaking-induced conversion). Prion diseases, including Creutzfeldt-Jakob disease in humans and chronic wasting disease in deer, are caused by misfolded prion proteins that template their abnormal shape onto normal copies. RT-QuIC exploits this seeding behavior: a patient’s cerebrospinal fluid sample is added to a well containing recombinant prion protein and ThT, then the plate is subjected to cycles of shaking and incubation. If prion seeds are present in the sample, they trigger the recombinant protein to form amyloid fibrils, and the ThT fluorescence signal climbs.

⁹

RT-QuIC has transformed prion diagnostics because it amplifies tiny amounts of misfolded protein into a detectable signal. Before this assay existed, definitive prion diagnosis often required brain biopsy or autopsy. Now, a spinal tap can give an answer with high sensitivity and specificity. The ThT readout is central to the assay’s design: it provides a simple, real-time fluorescence curve that indicates whether seeding activity is present.

Parkinson’s Disease and Alpha-Synuclein Research

ThT is not limited to Alzheimer’s-related amyloid-beta or prion proteins. In Parkinson’s disease research, ThT plays two roles. First, it serves as the standard probe for tracking aggregation of alpha-synuclein, the protein whose misfolded clumps (Lewy bodies) are the pathological hallmark of Parkinson’s. Researchers have used ThT fluorescence alongside time-resolved spectroscopy to monitor changes in microviscosity during alpha-synuclein aggregation, capturing transient states that occur before mature fibrils appear.

¹⁰

Second, the ThT assay forms the front end of drug-screening pipelines aimed at finding compounds that block alpha-synuclein aggregation. In one screening campaign, a ThT-based fibrillation assay was used to sift through over 1,200 FDA-approved small molecules, identifying 30 that inhibited alpha-synuclein fibril formation. Those 30 hits were then filtered through a cell-based assay to confirm their activity in a biological context.

¹¹

High-Throughput Drug Discovery

The ThT assay’s simplicity and plate-reader compatibility make it a natural fit for large-scale compound screening. Researchers use it both to look for molecules that prevent amyloid fibrils from forming and to find molecules that break apart fibrils already formed. In one high-throughput study, a fluorescent readout assay employing topology-sensitive dyes was used to screen a library of roughly 3,500 compounds, including known drugs, natural products, and synthetic molecules, for binding to amyloid-beta aggregates.

¹²

ThT-based assays have also been used to evaluate compounds that disrupt transthyretin (TTR) amyloid, which causes a form of hereditary amyloidosis affecting the heart and nerves. In one screen, a ThT post-treatment assay identified lead compounds that selectively disrupted TTR amyloid among a set of chemical hits.

¹³

When ThT Gets It Wrong

For all its usefulness, the ThT assay has well-documented pitfalls that researchers need to watch for. The most troublesome is interference from other compounds present in the experiment. Strongly colored or fluorescent molecules like curcumin and quercetin, both popular polyphenols studied as potential amyloid inhibitors, can dramatically distort ThT fluorescence readings. Curcumin at concentrations as low as 0.01 micromolar was enough to bias the ThT signal associated with amyloid-beta fibrils. Even resveratrol, which does not absorb or emit light at ThT’s wavelengths, interfered with the assay, likely by competing with ThT for binding sites on the fibrils or by interacting directly with the dye molecule.

¹⁴

This matters because many of the compounds researchers want to test as aggregation inhibitors happen to be the same kinds of polyphenolic molecules that interfere with ThT. A compound might appear to block amyloid formation when it is really just quenching the dye’s fluorescence. Good practice involves running control experiments without ThT, using complementary detection methods like electron microscopy or circular dichroism, and checking whether the test compound absorbs light at ThT’s excitation or emission wavelengths.

Measurement conditions also matter. How often you read fluorescence during a kinetics experiment can affect reproducibility, because the excitation light itself can influence the aggregation process or photobleach the dye. Researchers have flagged measurement frequency as an underappreciated source of variability between labs running what should be the same experiment.

⁴

Phototoxicity in Live Cells

Researchers sometimes use ThT in live-cell experiments, for example to watch amyloid form inside or on the surface of cells in real time. Here, an additional concern arises: phototoxicity. ThT accumulates in mitochondria, the energy-producing compartments of cells, in a way that depends on the mitochondrial membrane potential. At low concentrations with minimal light exposure, this accumulation actually makes ThT a useful indicator of mitochondrial health. But when ThT concentration and blue light exposure both increase, the combination causes the mitochondrial membrane potential to collapse. Neither ThT alone nor blue light alone produces this effect; it is the pairing that is toxic.

¹⁵

This means researchers doing live-cell imaging with ThT need to carefully control both the dye concentration and the intensity and duration of their excitation light. Too much of either, and the experiment starts damaging the very cells being observed.

From ThT to PiB and the Birth of Amyloid Brain Imaging

ThT itself cannot cross the blood-brain barrier efficiently enough for brain imaging in living people, and its permanent positive charge makes it poorly suited for injection. But the ThT molecular scaffold inspired one of the most important diagnostic tools in Alzheimer’s research: Pittsburgh Compound B, or PiB. Chemists found that removing the methyl group responsible for ThT’s positive charge produced a family of neutral benzothiazole-aniline compounds that penetrate the brain far more readily. PiB binds to amyloid-beta aggregates with roughly 200 times greater affinity than ThT, with a reported binding constant around 4.3 nanomolar compared to ThT’s 890 nanomolar.

¹⁶

Labeled with a radioactive carbon isotope, PiB became the first widely used PET tracer for imaging amyloid plaques in the brains of living patients. Its success opened the door to subsequent FDA-approved amyloid PET tracers and fundamentally changed how clinical trials for Alzheimer’s drugs are designed: instead of waiting for cognitive decline, researchers could directly measure whether a drug was clearing amyloid from the brain. The lineage from ThT to PiB to approved imaging agents is one of the clearest examples in neuroscience of a basic lab reagent inspiring a clinical breakthrough.

Next-Generation Probes Built on the ThT Scaffold

Researchers continue to modify ThT’s structure to address its limitations. One area of active development is near-infrared (NIR) probes. ThT fluoresces in the green-yellow range, which does not penetrate tissue well and overlaps with background fluorescence from biological molecules. By extending the conjugated system of the ThT scaffold with a thiophene bridge and tuning the molecule’s water solubility, one research group designed probes that fluoresce in the NIR window, penetrate the blood-brain barrier, and light up only upon binding to amyloid-beta plaques. These probes stay dark in solution and switch on when they encounter aggregated protein, preserving ThT’s appealing on/off behavior while working at wavelengths better suited to imaging in living animals.

¹⁷

Other modifications aim to combine ThT’s readout with other detection methods. A combined ThT and Congo Red fluorescence assay, for instance, uses both dyes together to provide multiple independent criteria for confirming that a sample contains amyloid fibrils rather than some other type of aggregate. And beyond protein aggregation entirely, engineered DNA structures have been designed to bind ThT with high affinity, producing a fluorescent signal that can be used to build label-free biosensors for various analytes.

¹⁸

Bacterial Biofilms and Functional Amyloids

Amyloid is not always a sign of disease. Many bacteria deliberately produce amyloid fibers as structural components of their biofilms, the slimy communities that help bacteria stick to surfaces and resist antibiotics. Curli fibers, produced by E. coli and related species, are among the best-studied functional amyloids.

¹⁹

Because curli share the cross-beta-sheet architecture of disease-associated amyloids, ThT binds to them and fluoresces in exactly the same way. Microbiologists use ThT fluorescence to study biofilm formation dynamics, to screen for genetic mutants that cannot produce curli, and to test whether antimicrobial compounds can disrupt the amyloid component of biofilms. This is a growing area of interest because biofilm-related infections in hospitals are notoriously difficult to treat, and targeting the amyloid scaffold that holds the biofilm together could be a novel therapeutic strategy.

Environmental and Analytical Sensing

ThT’s sensitivity to its binding environment has attracted interest outside of biology altogether. Because its fluorescence depends on how rigidly it is held in place, any system that constrains ThT’s molecular rotation can produce a detectable signal. Researchers have exploited this property to build sensors for metal ions: in one approach, ThT was incorporated into cerium-based coordination polymer nanoparticles to create a fluorescence sensor for detecting copper ions in electronic waste and biological samples.

DNA-based biosensors represent another frontier. By designing DNA sequences that fold into specific three-dimensional shapes capable of binding ThT tightly, researchers have created sensors where the presence of a target analyte triggers a structural change in the DNA, which in turn switches ThT fluorescence on or off. These sensors avoid the need for covalently attached fluorescent labels, making them cheaper and simpler to produce.

¹⁸

These applications are still largely in the proof-of-concept stage, but they illustrate how a molecule originally adopted for a narrow purpose in protein biochemistry has turned out to have a versatile and generalizable sensing mechanism. ThT’s future may be as much about what it can detect beyond amyloid as about the amyloid work that made it famous.